Teva Launches Generic Amikin Injection - MPR
OPHTAL - ADC.sk
5502943 - Henry Schein Medical
New CEO will lead Teva at top of new year—Chutes & Ladders
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
Equaline Headache Relief, Extra Strength, Tablets | Pain Relief & Fever | Mackenthuns
Q&A: Electronic inhaler system helps patients improve asthma control
Teva's Huntington drug launch on hold after FDA rejection | Fierce Biotech
United Kingdom first to grant license for Teva's ophthalmology biosimilar Ongavia
United Kingdom first to grant licence for Teva's ophthalmology biosimilar Ongavia (ranibizumab)▽
Teva Receives Marketing Authorization in Europe for Lucentis Biosimilar Ranivisio - Eyewire+
Teva's flagship drug Austedo scores new approval at the FDA
Pharma has set its sights on ophthalmology opportunities
First Lawsuit Filed Over Elmiron Eye Damage - Pelczar v. Teva Branded Pharmaceuticals R&D et al - Interstitial Cystitis Network
USFDA warns of Teva Pharma ADHD drug Adderall shortage
Kenalog Generic Triamcinolone Acetonide - Teva - Stag Medical Supply.
Teva joins forces with Icelandic firm to gain edge on biosimilars | The Times of Israel
Xylometazoline 1 mg spray Teva - 10 ml | Medische Vakhandel
Teva launches generic version of Celebrex caps | Drug Store News
United Kingdom first to grant licence for Teva's ophthalmology biosimilar Ongavia (ranibizumab)▽ | Business Wire
Teva's New CEO Francis Takes Over A Steadier – Though Still Rocky – Organization :: Scrip
Bausch Health's plans to acquire Allegro's ophthalmology assets
Ophtal tekutina oční 2 x 50ml - Příbalový leták | Pilulka.cz
Teva Receives FDA-Approval for Smartphone-Linked Digital Inhaler - Docwire News
UK First to Grant License for Teva | OBN
Teva wins U.K. approval for Lucentis biosimilar (NYSE:TEVA) | Seeking Alpha
EpiPen litigation comes back to haunt Teva
